Among ten selected candidate circRNAs, up-regulated circRNA annexin A2 (circ-ANXA2) seen to have the highest value in diagnosis with an AUC of 0.832, indicating that circ-ANXA2 may serve as a promising biomarker for detecting AML. This evidence concerns the gene ANXA2 and acute myeloid leukemia.